AI could slash drug discovery: DeepMind CEO Hassabis reveals; global healthcare
Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing years of research to months. DeepMind's AI models streamline drug candidate identification, enhance precision, and lower failure rates. This breakthrough promises faster access to treatments, reduced costs, and a new era of AI-powered medical research.
Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing years of research to months. DeepMind's AI models streamline drug candidate identification, enhance precision, and lower failure rates. This breakthrough promises faster access to treatments, reduced costs, and a new era of AI-powered medical research.
